Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGWBO:RHK -2.24%81 PEG Ratio is 3.24 as of Jul. 20, 2026, which is 26% below its 10-year median of 4.38. GuruFocus rates WBO:RHK with a GF Score™ of 81/100 and a GF Value™ of €13.56. The stock has 3 warning signs investors should review. Among 224 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 76.34% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Rhoen Klinikum AG's PEG Ratio or its related term are showing as below:
WBO:RHK'
s PEG Ratio Range Over the Past 10 Years
Min: 2.96 Med: 4.38 Max: 21.41
Current: 3.26
During the past 13 years, Rhoen Klinikum AG's highest PEG Ratio was 21.41. The lowest was 2.96. And the median was 4.38.
WBO:RHK's PEG Ratio is ranked worse than 76.34% of 224
companies
in the Healthcare Providers & Services industry
Industry Median: 1.42
vs WBO:RHK: 3.26
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Rhoen Klinikum AG (WBO:RHK) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Rhoen Klinikum AG PEG Ratio Related Terms
Rhoen Klinikum AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Rhoen Klinikum AG (WBO:RHK) has a PEG Ratio of 3.24 as of Jul. 20, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Rhoen Klinikum AG and its competitors. This is 26% below median its historical median of 4.38. Over the past decade, Rhoen Klinikum AG's PEG Ratio has ranged from 2.96 to 21.41. According to the industry distribution chart, Rhoen Klinikum AG ranks #171 out of 224 companies in the Healthcare Providers & Services industry, placing it in the top 76.3%.
Is Rhoen Klinikum AG's PEG Ratio too high?
Rhoen Klinikum AG's current PEG Ratio of 3.24 is 26% below median its 10-year median of 4.38. Over the past 10 years, this metric has ranged from a low of 2.96 to a high of 21.41. The Healthcare Providers & Services industry median PEG Ratio is 1.42. Rhoen Klinikum AG's value of 3.24 is 128.2% above this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #171 out of 224 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Rhoen Klinikum AG has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #171 out of 224 companies for PEG Ratio. This places Rhoen Klinikum AG in the lower half of its industry. The industry median PEG Ratio is 1.42. Rhoen Klinikum AG's value of 3.24 is 128.2% above this benchmark. Historically, Rhoen Klinikum AG's own PEG Ratio has ranged from 2.96 to 21.41 over the past decade. While the company's 10-year median is 4.38 vs. the industry median of 1.42, Rhoen Klinikum AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.42, based on 224 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current PEG Ratio of 3.24 is 128.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current PEG Ratio is 3.24, which is 26% below median its own 10-year median of 4.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current PEG Ratio of 3.24. The stock's GF Value™ is €13.56, compared to a current price of €13.10 — trading 3.4% below its estimated fair value. The current PEG Ratio is 3.24, which is 26% below median its 10-year median of 4.38 and 128.2% above the Healthcare Providers & Services industry median of 1.42. Rhoen Klinikum AG's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current PEG Ratio is 3.24 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of €13.10 is trading 3.4% below its estimated GF Value™ of €13.56.
Key valuation signals for WBO:RHK:
PEG Ratio: 3.24 (26% below median its 10-year median of 4.38)
GF Value™: €13.56 vs. price of €13.10 (3.4% below fair value)
Industry Position: 128.2% above the Healthcare Providers & Services median (#171 of 224)
No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
81GF Score
Get the complete analysis for WBO:RHK
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:RHK has been successfully added to your 
